Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation
- DOI
- 10.3390/biomedicines9040380
- Published
- 2021-04-03
- Container
- Biomedicines
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines9040380,
title = {Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation},
author = {Alexis Laurent and Philippe Abdel-Sayed and Anthony Grognuz and Corinne Scaletta and Nathalie Hirt-Burri and Murielle Michetti and Anthony S. de Buys Roessingh and Wassim Raffoul and Peter Kronen and Katja Nuss and Brigitte von Rechenberg and Lee Ann Applegate and Salim E. Darwiche},
year = {2021},
journal = {Biomedicines},
doi = {10.3390/biomedicines9040380},
url = {https://doi.org/10.3390/biomedicines9040380}
}RIS
TY - JOUR TI - Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation AU - Alexis Laurent AU - Philippe Abdel-Sayed AU - Anthony Grognuz AU - Corinne Scaletta AU - Nathalie Hirt-Burri AU - Murielle Michetti AU - Anthony S. de Buys Roessingh AU - Wassim Raffoul AU - Peter Kronen AU - Katja Nuss AU - Brigitte von Rechenberg AU - Lee Ann Applegate AU - Salim E. Darwiche PY - 2021 JO - Biomedicines DO - 10.3390/biomedicines9040380 UR - https://doi.org/10.3390/biomedicines9040380 ER -
APA
Laurent, A., Abdel-Sayed, P., Grognuz, A., Scaletta, C., Hirt-Burri, N., Michetti, M., Roessingh, A. S. D. B., Raffoul, W., Kronen, P., Nuss, K., Rechenberg, B. V., Applegate, L. A., & Darwiche, S. E. (2021). Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation. Biomedicines. https://doi.org/10.3390/biomedicines9040380
Source records
- crossref · retrieved 2026-11-10T18:54:50.314Z